Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
BACKGROUND
Disintegrants are the key excipients administered in tablet formulations to boost the decomposition of the tablet into smaller pieces in the gastrointestinal environment, thereby increasing the available surface area and enhancing a more rapid release of the active ingredient.


OBJECTIVE
Polysuccinimide (PSI), a biodegradable polymer synthesized from aspartic acid, was reacted with starch and fully assessed by CHN, (1)H-NMR, and FTIR.


METHODS
PSI-grafted starch (PSI-St) was synthesized and applied as a disintegrant in the formulation of a rapidly disintegrating tablet of Ondansetron, a nausea and vomiting medicine. The tablet formulated with the newly developed superdisintegrant was evaluated for hardness, friability, disintegration time, and dissolution rate, and the results were compared with tablets formulated with an identical composition of test formulation differing only in type of disintegrant.


RESULTS
Tablets prepared with starch and tablets prepared with sodium starch glycolate (SSG) were used as negative and positive controls, respectively. Dissolution study results indicated that although the onset of disintegration action was faster for SSG than PSI-St, higher amounts of drug were released from tablets formulated from PSI-St than from those formulated from SSG during 10 min.


CONCLUSIONS
It was concluded that the novel synthesized superdisintegrant has an appropriate potential for the application in the formulation of fast dissolving tablets.
a Biotechnology Research Center, Tabriz University of Medical Sciences , Tabriz , Iran and.
Mozhgan
M
Sadeghi
b Drug Applied Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.
Salar
S
Hemmati
b Drug Applied Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.
Hamed
H
Hamishehkar
D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000737:chemistry; D002626:Chemistry, Pharmaceutical / Q000379:methods; D005079:Excipients / Q000737:chemistry; D006244:Hardness; D017294:Ondansetron / Q000737:chemistry*; D010455:Peptides / Q000737:chemistry*; D012995:Solubility; D013213:Starch / Q000031:analogs & derivatives / Q000737:chemistry*; D013607:Tablets / Q000737:chemistry*; D013678:Technology, Pharmaceutical / Q000379:methods
D005079:Excipients; D010455:Peptides; D013607:Tablets; C025252:poly-DL-succinimide; D001224:Aspartic Acid; D017294:Ondansetron; D013213:Starch; C048390:sodium starch glycolate
Ondansetron; polylsuccinimide; rapidly dissolving tablet; starch; superdisintegrant